drugset / Trial / NCT00321009
LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
RandomizedSingle-groupOpen-labelPrevention
Summary
To prospectively evaluate the utility of enoxaparin vs. oral warfarin in reduction of echocardiographic indices of LV mural thrombus. The primary outcome is the presence of LV mural thrombus at 3.5 months. The secondary outcome is cost analysis comparing the two arms.
Timeline
- Start
- 2000-03
- Primary completion
- —
- Completion
- 2004-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | 1 mg/kg | Subcutaneous |